Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com 

Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Cerebras is a stock to avoid in a cash-out environment where companies, executives, employees and early investors are selling to buyers. Per a WSJ report cited by @wallstengine, Nvidia's AI chip business is over 400x larger than Cerebras and growing nearly as fast, yet Cerebras trades around 134x trailing revenue, more than 5x Nvidia's multiple. x.com 

Cerebras is a gamble, not a generational buying opportunity. It hasn't really proven anything yet and is burning cash, so by the time its technology is widely used it could be too late. It could become huge, but beating a behemoth like Nvidia takes more than good technology. x.com  x.com 

Cerebras is a speculative, high-risk, high-reward bet on faster inference that could make its $44B market cap a multi-bagger if it works. Putting the whole processor and memory on one wafer wins on speed, not cheaper memory, since on-chip SRAM costs more per bit than HBM; Nvidia is answering via Groq. G42 and MBZUAI were 86% of 2025 revenue, but the ramp ahead is tied to OpenAI. The $160s level has held as support four times since the IPO. Size it to one's capital-preservation goals. x.com 

Cerebras is an unattractive stock to hold now, even though ultrafast speed is a feature companies would happily pay for. Controversy over OpenAI's ultrafast running on Nvidia chips, the share lockup expiration and insider selling outweigh the chance that OpenAI's next 6.1 Sol ultrafast actually runs on Cerebras chips. x.com 

Cerebras at about a $100B market cap already prices in its execution upside aggressively, leaving downside risk. The bull case is real: it is a genuine new architecture in AI compute, with OpenAI's $20B+ contract plus Amazon Web Services, Meta, Perplexity, GSK, Mistral, Notion and AlphaSense diversifying it away from G42 in the UAE. But Nvidia's Vera Rubin ramp in the second half of 2026, a possible Nvidia absorption of Groq and the CUDA moat weigh on it. A position might make sense nearer $200. … Show more

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras is not worth owning because its proprietary stack faces limited broad adoption. The attached analysis says NVIDIA-aligned cloud operators are unlikely to deploy Cerebras hardware, while Groq LPUs fit NVIDIA's software ecosystem more easily. It also flags Cerebras' scaling and deployment friction, despite solid product-market fit with marquee customers. x.com